Merck (MRK) is said to reorganise its main Pharma unit and form a separate cancer unity, WSJ reports

Merck's decision to reorganize its main Pharma unit and create a separate cancer unit could signal a strategic shift aimed at enhancing focus on oncology, a sector that has seen significant growth and investment.

Newsquawk StaffPublished On the live feed at 3 more headlines followed before this page went public
Newsquawk headlinesUTC

Domino's Pizza Inc. (DPZ) Q4 2025 (USD): EPS 5.35 (exp. 5.38), Revenue 1.54bln (exp. 1.52bln); Q4 SSS 3.7% (exp. 2.3%)

Gilead (GILD) is to buy Arcellx (ACLX) for USD 7.8bln

Merck (MRK) is said to reorganise its main Pharma unit and form a separate cancer unity, WSJ reports

Newsquawk Daily US Opening News - 23rd February 2026

EU sells EUR 6.092bln vs exp. EUR 7bln 2.625% 2028, 3.125% 2030 and 3.375% 2038 EU Bond

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This move may also attract attention from investors looking for specialized growth opportunities within pharmaceuticals, potentially impacting the company's stock performance and broader market sentiment towards the sector.

Related headlines

The whole workspace, free to try.

Try it free